Biogen's Controversial Alzheimer's Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study Data
Biogen's Controversial Alzheimer's Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study Data
Briefly

To say that Biogen's Alzheimer's drug aduhelm is controversial wouldn't do its rocky road to approval justice.

[

]

[

...

]

Biogen's Controversial Alzheimer's Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study DataBiogen's Controversial Alzheimer's Drug Was Connected to a Patient Death, Just As the Company Presented Its Final Study Data Briefly